InSight Biopharmaceutical

About

InSight Biopharmaceutical develops biosimilar drugs with properties virtually identical to other previously approved drugs. The company has focused on introducing biosimilars to major markets through strategic alliances. Insight Biopharmaceutical's portfolio consists of a wide range of biosimilars in the fields of fertility, oncology, neurology, and rheumatology. In 2017, the company's intellectual property and assets were sold to Estonian company PharmaEstica Manufacturing and its Israeli partner. InSight is conducting the acquisition through InSight Innovation Ltd, a subsidiary it established specifically for the deal.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

InSight Biopharmaceutical — Full Company Profile (machine-readable)

Biosimilar and Generic Drug Development

About

Facts

Name	InSight Biopharmaceutical
Slug	insight-biopharmaceuticals
Type	Israeli Startup
Founded	1995
HQ city	Rehovot
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Acquired
Public stage	Acquired
Total raised (USD)	0
Website	http://www.insight.co.il
Crunchbase ID	insight-biopharmaceutical
Israeli Companies Registrar	515812501

Acquisitions (2)

Date	Target	Amount	Type
2019-01	Undisclosed	$2,500,000
2017-07	Undisclosed	$3,000,000

Team (1)

Name	Role	LinkedIn
Naim Tamari

News mentions (5)

Jan 13, 2019 — www.calcalistech.com: Article
Jul 4, 2018 — en.globes.co.il: Article
Mar 28, 2018 — www.calcalistech.com: Article
Jul 18, 2017 — www.globes.co.il: Article
Jun 23, 2011 — www.faqs.org: Article

About

Sectors & technology

Highlights

Tags